Prostate Cancer - Localized Adenocarcinoma Proton Therapy
NCT ID: NCT03285815
Last Updated: 2017-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
156 participants
INTERVENTIONAL
2016-05-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Arm 1: Proton therapy 3CGE x 20days = Total 60 CGE for 4 weeks.
Arm 2: Proton therapy 4.7CGE x 10days = Total 47 CGE for 2 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Proton Therapy 60 CGE
60 CGE (3CGE X 20) for 4wks
Proton Therapy
Proton Therapy 47 CGE
47 CGE (4.7CGE X 10) for 2wks
Proton Therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Proton Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ECOG performance status:0-1
* Signed study specific informed consent prior to study entry.
Exclusion Criteria
* Evidence of distant metastasis previous irradiation for the tumor in the same location
* Adjuvant anti-androgenic hormonal therapy High risk group (NCCN guide line)
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Center, Korea
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kwan Ho Cho
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kwanho Cho
Role: PRINCIPAL_INVESTIGATOR
National Cancer Center, Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kwanho Cho
Ilsan, Gyenggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCC 2016-0120
Identifier Type: -
Identifier Source: org_study_id